It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.
Doctors also expect some patients will hesitate to take Leqembi due to its limited impact and potential side effects. They say it will take years to learn how best to deploy the drug and that work must be done to improve diagnosis.
“This is the start of a very exciting journey,” said Dr. Ambar Kulshreshtha, a suburban Atlanta family physician focused on dementia patients.
More than 6 million Americans, and millions more worldwide, have Alzheimer’s disease, the most common cause of dementia. There’s no cure, but Leqembi clears a sticky brain protein called amyloid that’s a key indicator of Alzheimer’s.
Studies showed that it can delay the progression of the disease by a few months when given to people with mild symptoms. Some experts say the delay may be too subtle for patients to notice.
Related articles
Britain's new bonkers EV: Callum Skye is an £80k electric buggy built in Warwickshire
Britain has a new sports car. But it's not like anything else you've seen on the road before.Callum,2024-05-21Auditors can't locate former St. Louis circuit attorney to complete state audit
ST. LOUIS (AP) — A state examination of the office that handles criminal prosecutions in St. Louis i2024-05-21John Swinney expected to lead Scotland after being confirmed as Scottish National Party leader
LONDON (AP) — Scotland’s former deputy first minister, John Swinney, was confirmed Monday as head of2024-05-21RuPaul's Drag Race Australia judge Rhys Nicholson lists unique Coburg townhouse for $850K
Comedian Rhys Nicholson and his husband Kyran have listed their Coburg townhouse for sale with a pri2024-05-21Yvette Fielding says her Most Haunted co
Yvette Fielding claims her Most Haunted co-star Derek Acorah was a fake who tried to grope and kiss2024-05-21A subset of Alzheimer's cases may be caused by two copies of a single gene, new research shows
WASHINGTON (AP) — For the first time, researchers have identified a genetic form of late-in-life Alz2024-05-21
atest comment